If you or a loved one are experiencing treatment-resistant metastatic prostate cancer, a revolutionary breakthrough in radiopharmacology is a new Theranostics treatment offering new hope. University Cancer & Blood Center is pioneering a recently approved new treatment for advanced prostate cancer that tests positive for prostate-specific membrane antigen (PSMA). A pair of new drugs seeks out and binds to PSMA-positive cells, then delivers therapeutic radiation directly to the cancer, for highly targeted treatment that minimally impacts surrounding tissues. Watch as this video provides an in-depth explanation of this groundbreaking approach to treating prostate cancer.

To find out if you may be a candidate for this treatment
for advanced prostate cancer, call 706-353-2990 or visit [ Ссылка ]

свернуть